enGene Therapeutics Inc

enGene Therapeutics Inc (ENGN) Price Prediction & Forecast

$1.680

-0.039 (-2.33%)At close

Price Predictions

1-Day Price Prediction
-1.62%
1-Week Prediction
-1.88%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

ENGN Prediction & Forecast by Similar Chart Analysis

Alphio's ENGN stock price prediction model matches the current enGene Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.65 (-1.62%). The 1-week path is $1.65 (-1.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy enGene Therapeutics Inc Stock?

enGene Holdings Inc is not a good buy right now due to significant financial losses and negative analyst sentiment. The current price is $1.45, which is 88.2% below its 52-week high of $12.25, indicating a substantial decline. Additionally, the RSI is at 23.7, suggesting the stock is oversold, but this could reflect ongoing issues rather than a buying opportunity. The company reported a net loss of $30.23 million in Q2 2026, which is wider than the previous year's loss, and its forward P/E ratio is 0, indicating no expected earnings growth. The main risk is the recent downgrade by Morgan Stanley, which has reduced its price target to $1, reflecting low confidence in the company's future performance.

ENGN stock price ended at $1.68 on Thursday, after losing -2.33%

enGene Therapeutics Inc (ENGN) last closed at $1.6799999, losing -2.33%. These facts feed the 1-day and 1-week ENGN price prediction above.

Forecast Drivers

enGene Therapeutics Inc (ENGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

Similar Chart Patterns

Stocks whose recent price path most closely matches ENGN, ranked by similarity.

Seasonality analysis for ENGN

Historically the probability of a positive November return for ENGN is 20.93%. February offers the highest probability of a positive month at 51.72%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for ENGN

MonthMin PriceAvg PriceMax PricePotential ROI
Nov 2026$3.22$3.38$4.04+101.34%
Dec 2026$3.67$4.26$4.68+153.85%

In 2026, enGene Therapeutics Inc (ENGN) is projected to range from $3.22 to $4.68.

enGene Therapeutics Inc 2026 monthly forecast

Nov 2026 ENGN forecast
Potential ROI: 101.34%

In Nov 2026, enGene Therapeutics Inc is projected to average $3.38, with a low of $3.22 and high of $4.04.

Dec 2026 ENGN forecast
Potential ROI: 153.85%

In Dec 2026, enGene Therapeutics Inc is projected to average $4.26, with a low of $3.67 and high of $4.68.

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading